Basket

0565763 - BTÚ 2023 RIV CH eng J - Journal Article
Šeborová, K. - Koucká, K. - Spalenkova, A. - Holý, P. - Ehrlichová, M. - Sychra, T. - Chen, L. - Bendale, H. - Ojima, I. - Sandoval-Acuna, Cristian - Truksa, Jaroslav - Souček, P. - Václavíková, R.
Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model.
Frontiers in Pharmacology. Roč. 13, NOV 9 2022 (2022), č. článku 971905. ISSN 1663-9812. E-ISSN 1663-9812
R&D Projects: GA ČR(CZ) GA21-14082S
Institutional support: RVO:86652036
Keywords : ovarian carcinoma * resistance * paclitaxel * SB-T taxanes * efficacy * in vitro * in vivo
OECD category: Pharmacology and pharmacy
Impact factor: 5.6, year: 2022
Method of publishing: Open access
https://www.frontiersin.org/articles/10.3389/fphar.2022.971905/full
Permanent Link: https://hdl.handle.net/11104/0337429